Literature DB >> 17854472

Invasive pneumococcal disease in Portugal prior to and after the introduction of pneumococcal heptavalent conjugate vaccine.

Ricardo Dias1, Manuela Caniça.   

Abstract

The rates of invasive pneumococcal disease (IPD), serotype distribution and antimicrobial susceptibility prior to and after the introduction of the heptavalent pneumococcal conjugate vaccine in Portuguese children were evaluated. The changes in incidence of IPD in children under 1 year old between the two periods of the study was not significant (P=0.53), despite the 21% decline. In children under 18 years old there was a 27.7% decrease in vaccine serotypes. All nonvaccine serotypes increased 71.4%. The decrease in vaccine serotypes was more impressive during the first year of life (-54.8%) than for children between 1 and 5 years of age (-19.1%). Among children under 1 year old, penicillin nonsusceptible isolates declined between the two periods of the study (47.2% vs. 25.0%) (P=0.03), as did those of cefotaxime and ceftriaxone nonsusceptible isolates. No changes were observed for isolates nonsusceptible to tetracycline and macrolides. The serotypes of these nonsusceptible isolates differed after the introduction of vaccine (P=0.01). Multiresistance increased 57.1% after the introduction of vaccine. Multiresistant isolates with vaccine serotype declined 42.9% (P<0.001), and nonvaccine serotypes appeared during the vaccination period (P<0.001). These findings suggest a replacement of vaccine serotypes by nonvaccine serotypes, mainly among nonsusceptible isolates.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17854472     DOI: 10.1111/j.1574-695X.2007.00283.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  11 in total

Review 1.  Serotype replacement in disease after pneumococcal vaccination.

Authors:  Daniel M Weinberger; Richard Malley; Marc Lipsitch
Journal:  Lancet       Date:  2011-04-12       Impact factor: 79.321

2.  Population structure of invasive Streptococcus pneumoniae isolates among Alaskan children in the conjugate vaccine era, 2001 to 2013.

Authors:  Karen M Miernyk; Lisa R Bulkow; Samantha L Case; Tammy Zulz; Michael G Bruce; Marcella Harker-Jones; Debby A Hurlburt; Thomas W Hennessy; Karen M Rudolph
Journal:  Diagn Microbiol Infect Dis       Date:  2016-07-07       Impact factor: 2.803

Review 3.  Humoral immune responses to Streptococcus pneumoniae in the setting of HIV-1 infection.

Authors:  Lumin Zhang; Zihai Li; Zhuang Wan; Andrew Kilby; J Michael Kilby; Wei Jiang
Journal:  Vaccine       Date:  2015-06-30       Impact factor: 3.641

4.  Temporal Variations among Invasive Pneumococcal Disease Serotypes in Children and Adults in Germany (1992-2008).

Authors:  Matthias Imöhl; Ralf René Reinert; Mark van der Linden
Journal:  Int J Microbiol       Date:  2010-06-30

5.  Temporal analysis of invasive pneumococcal clones from Scotland illustrates fluctuations in diversity of serotype and genotype in the absence of pneumococcal conjugate vaccine.

Authors:  J M Jefferies; A J Smith; G F S Edwards; J McMenamin; T J Mitchell; S C Clarke
Journal:  J Clin Microbiol       Date:  2009-11-18       Impact factor: 5.948

6.  Invasive Streptococcus pneumoniae infections in children and older adults in the north of Spain before and after the introduction of the heptavalent pneumococcal conjugate vaccine.

Authors:  E Pérez-Trallero; J M Marimon; M Ercibengoa; D Vicente; E G Pérez-Yarza
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-01-20       Impact factor: 3.267

7.  Simulated effect of pneumococcal vaccination in the Netherlands on existing rules constructed in a non-vaccinated cohort predicting sequelae after bacterial meningitis.

Authors:  Arno E Commandeur; Rogier C J de Jonge; Irene Koomen; Lodewijk Spanjaard; A Marceline van Furth; Caroline B Terwee
Journal:  BMC Infect Dis       Date:  2010-09-03       Impact factor: 3.090

8.  Macrolide susceptibility and serotype specific macrolide resistance of invasive isolates of Streptococcus pneumoniae in Germany from 1992 to 2008.

Authors:  Matthias Imöhl; Ralf René Reinert; Christina Mutscher; Mark van der Linden
Journal:  BMC Microbiol       Date:  2010-11-25       Impact factor: 3.605

9.  Pneumococcal serotypes in children in 4 European countries.

Authors:  Germaine Hanquet; Esther Kissling; Asuncion Fenoll; Robert George; Agnes Lepoutre; Tinne Lernout; David Tarragó; Emmanuelle Varon; Jan Verhaegen
Journal:  Emerg Infect Dis       Date:  2010-09       Impact factor: 6.883

10.  Invasive pneumococcal infections among persons with and without underlying medical conditions: implications for prevention strategies.

Authors:  Peter Klemets; Outi Lyytikäinen; Petri Ruutu; Jukka Ollgren; J Pekka Nuorti
Journal:  BMC Infect Dis       Date:  2008-07-22       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.